Literature DB >> 32539075

Association of Circadian Abnormalities in Older Adults With an Increased Risk of Developing Parkinson Disease.

Yue Leng1, Terri Blackwell2, Peggy M Cawthon2, Sonia Ancoli-Israel3, Katie L Stone2, Kristine Yaffe4,5,6.   

Abstract

Importance: Disruption in circadian activity rhythms is very common in older adults, particularly among those with neurodegenerative diseases, including Parkinson disease (PD). However, whether circadian disruption could be a prodrome for PD is unclear. Objective: To determine the association between rest-activity rhythm (RAR) and risk of incident PD and to explore whether this association is independent of nighttime sleep disturbances. Design, Setting, and Participants: The ancillary sleep study of the longitudinal cohort Osteoporotic Fractures in Men Study (MrOS) was conducted from December 1, 2003, to March 31, 2005. Of the 3135 community-dwelling men enrolled in the MrOS sleep study, 3049 had technically adequate RAR data; of these, 119 were excluded for having prevalent PD or missing incident data, leaving 2930 men without PD at baseline. Data were analyzed from February 1 through August 31, 2019. Exposures: Twenty four-hour RAR parameters (amplitude, mesor, robustness, and acrophase) generated by wrist actigraphy-extended cosinor analysis. Main Outcomes and Measures: Incident PD based on physician diagnosis. Multivariable logistic regression was used to determine the association between quartiles of RAR parameters and risk of incident PD.
Results: Among the 2930 men included in the analysis (mean [SD] age, 76.3 [5.5] years), 78 (2.7%) developed PD during 11 years of follow-up. After accounting for all covariates, the risk of PD increased with decreasing circadian amplitude (strength of the rhythm) (odds ratio [OR] per 1-SD decrease, 1.77; 95% CI, 1.30-2.41), mesor (mean level of activity) (OR per 1-SD decrease, 1.64; 95% CI, 1.22-2.21), or robustness (how closely activity follows a cosine 24-hour pattern) (OR per 1-SD decrease, 1.54; 95% CI, 1.14-2.07) (P < .005 for trend). Those in the lowest quartile of amplitude, mesor, or robustness had approximately 3 times the risk of developing PD compared with those in the highest quartile of amplitude (OR, 3.11; 95% CI, 1.54-6.29), mesor (OR, 3.04; 95% CI, 1.54-6.01), and robustness (OR, 2.65; 95% CI, 1.24-5.66). The association remained after further adjustment for nighttime sleep disturbances and duration in the lowest compared with the highest quartile (OR for amplitude, 3.56 [95% CI, 1.68-7.56]; OR for mesor, 3.24 [95% CI, 1.52-6.92]; and OR for robustness, 3.34 [95% CI, 1.45-7.67]). These associations were somewhat attenuated, but the pattern remained similar after excluding PD cases developed within 2 years after baseline in the lowest compared with the highest quartile (OR for amplitude, 2.40 [95% CI, 1.15-5.00]; OR for mesor, 2.76 [95% CI, 1.35-5.67]; and OR for robustness, 2.33 [95% CI, 1.07-5.07]). Acrophase was not significantly associated with risk of PD. Conclusions and Relevance: In this cohort study, reduced circadian rhythmicity was associated with an increased risk of incident PD, suggesting it may represent an important prodromal feature for PD. Future studies are needed to determine whether circadian disruption could also be a risk factor for PD and whether strategies to improve circadian function affect the risk of PD.

Entities:  

Year:  2020        PMID: 32539075      PMCID: PMC7296450          DOI: 10.1001/jamaneurol.2020.1623

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  11 in total

1.  Religiosity and Risk of Parkinson's Disease in England and the USA.

Authors:  Abidemi I Otaiku
Journal:  J Relig Health       Date:  2022-06-28

Review 2.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

Review 3.  Human circadian variations.

Authors:  Nicholas W Gentry; Liza H Ashbrook; Ying-Hui Fu; Louis J Ptáček
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

Review 4.  Circadian Rhythm Sleep-Wake Disorders in Older Adults.

Authors:  Jee Hyun Kim; Alexandria R Elkhadem; Jeanne F Duffy
Journal:  Sleep Med Clin       Date:  2022-06

5.  The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.

Authors:  Liang Kou; Xiaosa Chi; Yadi Sun; Chao Han; Fang Wan; Junjie Hu; Sijia Yin; Jiawei Wu; Yunna Li; Qiulu Zhou; Wenkai Zou; Nian Xiong; Jinsha Huang; Yun Xia; Tao Wang
Journal:  J Neuroinflammation       Date:  2022-06-06       Impact factor: 9.587

6.  Distressing dreams and risk of Parkinson's disease: A population-based cohort study.

Authors:  Dr Abidemi I Otaiku
Journal:  EClinicalMedicine       Date:  2022-06-08

Review 7.  Circadian disruption and human health.

Authors:  Anna B Fishbein; Kristen L Knutson; Phyllis C Zee
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

8.  Characterizing mild cognitive impairment in prodromal Parkinson's disease: A community-based study in China.

Authors:  Chenxi Pan; Yuqian Li; Jingru Ren; Lanting Li; Peiyu Huang; Pingyi Xu; Li Zhang; Wenbing Zhang; Min-Ming Zhang; Jiu Chen; Weiguo Liu
Journal:  CNS Neurosci Ther       Date:  2021-11-25       Impact factor: 5.243

9.  A Computational Analysis in a Cohort of Parkinson's Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes.

Authors:  Müge Yalçin; Deeksha Malhan; Alireza Basti; Ana Rita Peralta; Joaquim J Ferreira; Angela Relógio
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

10.  Induced Cognitive Impairments Reversed by Grafts of Neural Precursors: A Longitudinal Study in a Macaque Model of Parkinson's Disease.

Authors:  Florence Wianny; Kwamivi Dzahini; Karim Fifel; Charles Robert Eden Wilson; Agnieszka Bernat; Virginie Dolmazon; Pierre Misery; Camille Lamy; Pascale Giroud; Howard Michael Cooper; Kenneth Knoblauch; Emmanuel Procyk; Henry Kennedy; Pierre Savatier; Colette Dehay; Julien Vezoli
Journal:  Adv Sci (Weinh)       Date:  2022-02-09       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.